"China is one of the world's major producers of pharmaceuticals; the pharmaceutical sector achieved an annual compound growth rate of 16.6% between 1978 to 2000. The Chinese pharmaceutical market is expected to be among the top 10 pharmaceutical markets in the world by 2005 and the fifth largest by 2010.¡¨(The Chinese Pharmaceutical/Biotechnology Market Guide 2003)

According to the Southern Medical Economic Research Institute of the PRC, pharmaceutical market in the PRC will continue to grow at a rate higher than that of 2004. It is expected that there will be a lot of mergers and acquisitions taking place in the pharmaceutical industry.

The group, as the ten supporting pharmaceutical manufacturing enterprise of Yunnan provincial People's Government has earned its reputation for its high-quality products. Jiwa is on its track of transiting from producing generic products to focusing on core therapeutic categories. In the year 2005-2006, we will streamline the unprofitable products, focus on selling of the selected prime products, and continue to develop products of higher values. It is expected that there will be 5 new products to be launched in the year 2005-2006.